CLINICAL_TRIALS
trial_result
· 2019-03-21
Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01 [Phase 1]
Summary
Phase 1 trial investigating GLWL-01 in type 2 diabetes was terminated; results posted previously.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GLWL Research Inc. | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: TERMINATED | Results posted: 2019-03-21